NewsRoom Articles - Page 231 of 252

ThursdayAug 17, 2017 4:55 pm

SinglePoint, Inc. (SING) Set to Benefit from Growth in Bitcoin and Cannabis Markets

Payment solutions for cannabis industry Operator of cryptocurrency exchange Bitcoin payment solutions for retailers In its latest initiatives, SinglePoint, Inc. (OTC: SING) is showing that innovation, like politics, makes strange bedfellows. This diversified holding company specializing in acquisitions of small to mid-sized companies, with an emphasis on new technologies, is planning a marriage of cannabis and cryptocurrencies, both of which are rapidly growing opportunities. The company is developing a payment processing solution utilizing cryptocurrencies that is likely to find early application in the cannabis industry. Using its recently acquired $Weed and other cryptocurrencies, SinglePoint wants to help the cannabis industry…

WednesdayAug 16, 2017 5:07 pm

FDA Proposal Puts Spotlight on Big Tobacco and Industry Innovators

NetworkNewsWire Coverage: The black cloud over Big Tobacco has been swirling for decades, but few developments have cast a bigger shadow than the U.S. Food and Drug Administration’s recent proposal to reduce nicotine levels in cigarettes to non-addictive levels. The new plan1, originally unveiled on July 28, is expected to serve as a multi-year roadmap aimed at saving lives and significantly reducing the effects of tobacco-related diseases. The market effects of the nicotine push have proven to be colossal, with shares of two of the largest sellers of cigarettes in the United States suffering their largest single-day plunge since the…

WednesdayAug 16, 2017 4:56 pm

Investors Eye Sweet Spots in Canada’s Booming Cannabis Market

NetworkNewsWire Editorial Coverage: Canada is the mecca of the North American cannabis market, boasting legalization in every province and an array of investment opportunities, such as ABcann Global Corporation (TSX.V: ABCN) (OTCQB: ABCCF), a Canadian grower of medical marijuana. ABcann recently acquired ABcann Medicinals and boasts a recent IPO, appointment of a new medical consultant, and major expansion plans. As one of Canada’s most dominant growers of medical marijuana and one of the growers to meet the Canadian government’s stringent licensing requirements, ABcann could be positioned to see the post-IPO success achieved by Supreme Pharmaceuticals, Inc. (OTC: SPRWF) (TSX.V: FIRE),…

TuesdayAug 15, 2017 4:58 pm

Record Bitcoin Gains Indicate High Times Ahead for Cannabis Cryptocurrency

NetworkNewsWire Coverage: Within America’s explosive legal cannabis market—projected to potentially reach a staggering $50 billion valuation by 20261—legal uncertainties and blockades continue to pose challenges. One of these challenges is a lack of banking options for marijuana merchants, who are largely forced to conduct cash transactions, as cannabis businesses currently do not have the backing of the FDIC and, consequently, do not have access to traditional banking options. Necessity is the mother of invention, and enterprising companies are endeavoring to skirt federal restrictions and provide cannabis companies with innovative financial transaction options to meet their growing needs. One company racing…

MondayAug 14, 2017 5:00 pm

ABcann Global Corporation (TSX.V: ABCN) (OTCQB: ABCCF) Looks Strong for Investors in Booming Canadian Cannabis Market

ABcann’s low current market cap compared to similar companies offers an obvious opportunity for investors ABcann Global is one of Canada’s most dominant growers of medical marijuana and one of the growers to meet Canadian government’s stringent licensing requirements Major expansion of ABcann’s production capacity is underway An interesting opportunity for investors can be found in ABcann Global Corporation (TSX.V: ABCN) (OTCQB: ABCCF), a Canadian grower of medical marijuana. ABcann recently acquired ABcann Medicinals and boasts a recent IPO, appointment of a new medical consultant, and major expansion plans. ABcann is new to the public market, having launched its initial…

WednesdayAug 09, 2017 5:01 pm

ChineseInvestors.com, Inc. (CIIX) Seen Benefitting from Senate Committee Vote for Amendment Protecting Legal Cannabis

Unclear whether amendment will survive in final appropriations bill, but Congressional vote sends message to Attorney General Jeff Sessions CIIX is expanding in global market with online cannabidiol store in Shanghai, China, and brick-and-mortar unit to open in San Gabriel, California Consilium Global Research estimates that CIIX will outperform cannabis market to achieve revenues of $14.8 million by FY 2020 ChineseInvestors.com, Inc. (OTCQB: CIIX) and other cannabis companies were overjoyed by the July 27 affirmative voice vote by the Senate Appropriations Committee to approve an amendment to a “2018 Commerce, Justice and Science Bill” that bars the federal government from…

TuesdayAug 08, 2017 9:00 am

Absent Federal Banking Support, Cannabis Market Shows Growing Interest in Proprietary Bitcoin Payment Solutions

CBDWire Editorial Coverage: The legal marijuana industry continues its impressive growth, despite the inability to access a wide range of banking solutions, given that cannabis is still classified as a Schedule I substance by the Federal government. Similarly, bitcoin is a booming market, recently hitting an all-time high of $3,0001 per unit. These two fast-growing markets are already working together, providing investors with significant and diversified opportunities. Several companies, such as SinglePoint, Inc. (SING), First Bitcoin Capital Corp. (BITCF), Epazz, Inc. (EPAZ) and Bitcoin Services, Inc. (BTSC), are focused on innovative bitcoin-based payment solutions to benefit the legal marijuana industry…

MondayAug 07, 2017 1:56 pm

Moleculin Biotech (NASDAQ: MBRX) to Begin Preparing Clinical Testing Sites for Leukemia Treatment

NASDAQ Biotechnology Index up and climbing Developing new treatment for acute myeloid leukemia (AML) Lead candidate, Annamycin, now at phase II Since a rising sea lifts all boats, it’s decidedly good news for Moleculin Biotech, Inc. (NASDAQ: MBRX) that the NASDAQ Biotechnology Index (NBI) is enjoying a spring tide. The index has offered a year-to-date return of over 17 percent and seems set to keep climbing. This benign environment gives Moleculin an opportunity to advance work on its leading anti-cancer drug candidates. The company has begun to identify and prepare testing sites in Europe and has already appointed a Lead…

MondayAug 07, 2017 12:42 pm

Medical Innovation Holdings, Inc. (MIHI) Serving the Underserved with Telemedicine

Millions of Americans live in areas with little or no comprehensive health care MIHI establishing nationwide telemedicine network to provide specialty care Serving the underserved makes MIHI sole practitioner to millions There’s no doubt that the U.S. health care system is fractured. Our patchwork quilt of health care services leaves many citizens isolated and medically stranded. Far beyond the current contentious health care debate, millions of Americans live in areas that have chronically suffered with little or no health care services. For various reasons of geography, economics or social circumstance, certain populations in the country have far too few primary…

FridayAug 04, 2017 3:24 pm

7 Company Updates from this Week to Review

The last week has been quite busy for the global marijuana industry as companies continued to execute and work to create value for shareholders. Although the marijuana industry is comprised of some incredible companies, investors must be selective and focus on the real players. Today we have highlighted 7 developments that marijuana stock investors need to know about. Insys: Second Quarter Revenue Drops 38% Nasdaq-traded Insys Therapeutics (INSY) reported its second quarter financial results today and recorded a 38% drop in revenue when compared to the same quarter last year. Although this biotech cannabis stock has continued to execute, the…

News and publishing service for CBD related companies

Contact us: 303.498.7722